RIA Advisory Group’s Gilead Sciences GILD Stock Holding History

RIA Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,175	Closed	-$507K	–	131
2022 Q4	$507K	Buy	+6,175	New	+$489K	0.29%	52

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RIA Advisory Group's GILD Position: Q1 2023 in Review

RIA Advisory Group sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 6,175 shares — an estimated $507K sold.

RIA Advisory Group first reported a position in GILD in Q4 2022 and held it in 1 quarter. The position peaked at $507K in Q4 2022. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

RIA Advisory Group reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
RIA Advisory Group sold 6,175 Gilead Sciences shares in Q1 2023, an estimated $507K.
RIA Advisory Group first reported a position in Gilead Sciences in Q4 2022 and held it in 1 quarter.
RIA Advisory Group's Gilead Sciences position peaked at $507K in Q4 2022.
1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on RIA Advisory Group's 13F filing for Q1 2023, filed 25 Apr 2023.